Stay updated on DECIDE Clinical Trial: Dapagliflozin vs. Standard Care
Sign up to get notified when there's something new on the DECIDE Clinical Trial: Dapagliflozin vs. Standard Care page.

Latest updates to the DECIDE Clinical Trial: Dapagliflozin vs. Standard Care page
- ChecktodayChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedStatus updated to Completed with new dates; the previous 'Active, not recruiting' designation was removed.SummaryDifference0.4%

- Check22 days agoChange DetectedAdded Type 2 diabetes as a study topic and included a related topic link to MedlinePlus Genetics.SummaryDifference0.1%

- Check29 days agoChange DetectedThe update adds a new revision label (v3.4.2) and removes non-study topics and an older revision note, with no impact on the study details or user interactions on the page.SummaryDifference0.3%

- Check36 days agoChange DetectedAdded a site-wide notice regarding a lapse in government funding and the NIH operating status, and updated the revision from v3.4.0 to v3.4.1. These changes are administrative and do not affect study details or user actions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check43 days agoChange DetectedUI updates include a glossary display toggle and new metadata labels: 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and a Revision: v3.4.0. The corresponding older labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and Revision: v3.3.4 were removed.SummaryDifference0.1%

Stay in the know with updates to DECIDE Clinical Trial: Dapagliflozin vs. Standard Care
Enter your email address, and we'll notify you when there's something new on the DECIDE Clinical Trial: Dapagliflozin vs. Standard Care page.